Mobile Site ›

Hemoglobin A1c and the Estimated Average Glucose



Subscribe

Receive notification when new Hot Topics are published:

Introduction

Slide 1

July 2009

Welcome to Mayo Medical Laboratories' Hot Topics. These presentations provide short discussion of current topics and may be helpful to you in your practice.

Our presenter for this program is Amy K. Saenger, PhD, Director of the Central Clinical Laboratory in the Department of Laboratory Medicine & Pathology at Mayo Clinic in Rochester, Minnesota. Dr. Saenger will provide an overview of the diagnosis of diabetes and monitoring of the diabetic patient and discuss the advantages and disadvantages of hemoglobin A1c and fasting plasma glucose testing. She will define newly released recommendations from the American Diabetes Association and discuss the use and reporting of the estimated average glucose.

I will be discussing hemoglobin A1c testing and reporting of the estimated average glucose. This is a subject that has received much attention in both the clinical and laboratory realm due to the fact that there are major implications for measuring an accurate and precise HbA1c.

Introduction

 

Jump to section:


Key